During the past decade, Asklepios MVZ Nord SH GmbH, c/o AK St. Georg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Asklepios MVZ Nord SH GmbH, c/o AK St. Georg" are "Arthritis, Rheumatoid" (1 trials), "Axial Spondyloarthritis" (1 trials), "Plaque Psoriasis" (1 trials), "Psoriatic Arthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Asklepios MVZ Nord SH GmbH, c/o AK St. Georg" in a lesser frequency.

Most popular intervention types in "Asklepios MVZ Nord SH GmbH, c/o AK St. Georg" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Etanercept" (1 trials) and "Tofacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios MVZ Nord SH GmbH, c/o AK St. Georg" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Asklepios MVZ Nord SH GmbH, c/o AK St. Georg". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Asklepios MVZ Nord SH GmbH, c/o AK St. Georg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios MVZ Nord SH GmbH, c/o AK St. Georg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".